Volumetric Bone Mineral Density in Young Women with Turner’s Syndrome Treated with Estrogens or Estrogens plus Growth Hormone
Authors:
- Luisa CinquantaLCLuisa Cinquanta
- Giampiero I. BaroncelliGBGiampiero I. Baroncelli
- Paolo SimiPSPaolo Simi
- Simona RossiSRSimona Rossi
- Giuseppe SaggeseGSGiuseppe Saggese
- 1 July 2000
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 53 (2) , 72-76
Abstract
To explore the effects of estrogen replacement therapy (ERT) and recombinant growth hormone (GH) treatment on bone mineral density (BMD) in Turner’s syndrome, we assessed volumetric BMD (vBMD), which is less dependent on body and bone sizes, in these patients at final height. The areal BMD (aBMD) was measured in 26 young women with Turner’s syndrome (age range 17.5–25.0 years) by dual-energy X-ray absorptiometry, and vBMD was calculated. Patients were subdivided as group 1 (n = 12; ERT alone) and group 2 (n = 14; GH + ERT). Years of estrogen exposure were not different between the groups (group 1: 6.4 ± 1.5 years; group 2: 5.3 ± 1.7 years); in group 2, GH therapy was 5.3 ± 1.4 years. Final heights were significantly higher in group 2 than in group 1 (148.1 ± 3.0 vs. 142.0 ± 2.8 cm; p < 0.0001) as well as aBMD (1.073 ± 0.118 vs. 0.968 ± 0.122 g/cm2; p < 0.04). vBMD was higher in group 2 but not significantly different from group 1 (0.374 ± 0.030 vs. 0.358 ± 0.027 g/cm3; p = 0.169). aBMD was reduced with respect to the normative values in both groups (group 1: –1.97 ± 1.04 SDS, p < 0.0001 vs. 0; group 2: –0.93 ± 1.01 SDS, p < 0.005 vs. 0), whereas vBMD was not (group 1: –0.07 ± 0.79 SDS; group 2: 0.42 ± 0.82 SDS). Our data suggest that: in Turner’s syndrome GH administration improves final height and aBMD, but it does not significantly increase vBMD; aBMD reduction in Turner’s syndrome is likely due to the impaired growth and reduced bone size; Turner’s patients on ERT from adolescence show vBMD values in the normal range in young adulthood.Keywords
This publication has 4 references indexed in Scilit:
- Normal Volumetric Bone Mineral Density and Bone Turnover in Young Men with Histories of Constitutional Delay of PubertyThe Journal of Clinical Endocrinology & Metabolism, 1998
- Measurement of Volumetric Bone Mineral Density Accurately Determines Degree of Lumbar Undermineralization in Children with Growth Hormone DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 1998
- Growth in Bone Mass and Size--Are Racial and Gender Differences in Bone Mineral Density More Apparent than Real?The Journal of Clinical Endocrinology & Metabolism, 1998
- The dose-dependency of alcohol-induced hypoparathyroidism, hypercalciuria, and hypermagnesuriaBone and Mineral, 1992